A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions

Detalles Bibliográficos
Autores principales: Donzelli, Sara, Cioce, Mario, Sacconi, Andrea, Zanconato, Francesca, Daralioti, Theodora, Goeman, Frauke, Orlandi, Giulia, Di Martino, Simona, Fazio, Vito Michele, Alessandrini, Gabriele, Telera, Stefano, Carosi, Mariantonia, Ciliberto, Gennaro, Botti, Claudio, Strano, Sabrina, Piccolo, Stefano, Blandino, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306102/
https://www.ncbi.nlm.nih.gov/pubmed/35869553
http://dx.doi.org/10.1186/s12943-022-01617-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306102/
https://www.ncbi.nlm.nih.gov/pubmed/35869553
http://dx.doi.org/10.1186/s12943-022-01617-6

Ejemplares similares